Sun Pharma Surges on Landmark Organon Acquisition

Shares of Sun Pharma jumped over 5% after announcing the acquisition of Organon & Co., marking the largest takeover by an Indian pharma firm. The deal is expected to boost global scale, portfolio, and reach, though it involves significant debt, which the company aims to reduce within 3–4 years.